umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Adalimumab (Humira (R)) normalizes melanocortin receptor subtype 2, 3, and 4 expression in CD8+, CD14+, and CD19+leucocyte subsets in rheumatoid arthritis
Umeå University, Faculty of Medicine, Department of Clinical Microbiology, Clinical Immunology.
Umeå University, Faculty of Medicine, Department of Clinical Microbiology, Clinical Immunology.
Show others and affiliations
2014 (English)In: Scandinavian Journal of Rheumatology, ISSN 0300-9742, E-ISSN 1502-7732, Vol. 43, no Suppl. 127, 25-26 Meeting Abstr. PP119 p.Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
Informa Healthcare, 2014. Vol. 43, no Suppl. 127, 25-26 Meeting Abstr. PP119 p.
National Category
Immunology in the medical area
Identifiers
URN: urn:nbn:se:umu:diva-94906ISI: 000341757300038OAI: oai:DiVA.org:umu-94906DiVA: diva2:758942
Available from: 2014-10-28 Created: 2014-10-20 Last updated: 2017-12-05Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Nagaev, IvanNagaeva, OlgaMincheva-Nilsson, Lucia
By organisation
Clinical Immunology
In the same journal
Scandinavian Journal of Rheumatology
Immunology in the medical area

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 135 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf